Wave Life Sciences Ltd.

NASDAQ:WVE

Biotechnology

Healthcare
$2.72 +1.63%

+$0.10 today

Market cap
$536.46M
Beta
-1.33
P/E (TTM)
-6.6
EPS (TTM)
-$0.92
52W Low $5.02High $21.73

Volume 1.92M

Average 4.86M

Income Statement

Follow revenue through to earnings.

Revenue

$42.73M

FY 2025 · Annual

-60.5% YoY

Operating Income

-$215.38M

FY 2025 · Annual

Net Income

-$204.38M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue40.96M3.65M113.31M108.3M42.73M
Cost of Revenue00008.85M
Gross Profit40.96M3.65M113.31M108.3M33.88M
Gross Margin100.0%100.0%100.0%100.0%79.3%
Research & Development121.88M115.86M130.01M159.68M182.78M
Selling, General & Admin46.11M50.51M51.29M59.02M75.33M
Operating Expenses167.98M166.37M181.3M218.71M249.26M
Depreciation & Amortization9.84M10.11M9.21M8.66M8.85M
EBITDA(112.61M)(151.03M)(48.98M)(88.35M)(195.53M)
EBITDA Margin-274.9%-4138.9%-43.2%-81.6%-457.6%
Operating Income(127.02M)(162.72M)(68M)(110.4M)(215.38M)
Operating Margin-310.1%-4459.3%-60.0%-101.9%-504.1%
Interest Income30K00010.48M
Interest Expense00000
Other Income / Expenses4.57M1.58M9.81M13.4M11.01M
Income Before Tax(122.45M)(161.14M)(58.19M)(97.01M)(204.38M)
Pre-Tax Margin-298.9%-4416.1%-51.4%-89.6%-478.3%
Income Tax Expense(204K)681K(677K)00
Net Income(122.25M)(161.82M)(57.51M)(97.01M)(204.38M)
Net Margin-298.4%-4434.7%-50.8%-89.6%-478.3%
EPS (Basic)(2.36)(2.05)(0.54)(0.70)(1.21)
EPS (Diluted)(2.36)(2.05)(0.54)(0.70)(1.21)
Weighted Avg Shares51.83M78.86M106.1M138.28M168.65M
Weighted Avg Shares (Diluted)51.83M78.86M106.1M138.28M168.65M

WVE Earnings Waterfall · TTM

NASDAQ:WVE · Revenue to Net Income

Key Ratios

EPS$-1.06
Gross Margin90.4%
Net Margin-416.1%
P/E Ratio-9.8
P/S Ratio124.9

Analysis

$71.8M of revenue converted into -$183.6M of net income for the selected period. Gross margin is 90.4% and net margin is -416.1%, showing how much revenue survives after costs and taxes. EPS is $-1.06, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingOct 27, 2026
8-KCurrent reportOct 27, 2026
10-QQuarterly reportOct 27, 2026
SC 13G/ASC 13G/A filingOct 27, 2026
ARSARS filingOct 14, 2026

How much revenue does WVE generate?

Wave Life Sciences Ltd. (WVE) reported $42.73M of revenue in fiscal 2025.

Is WVE profitable?

Wave Life Sciences Ltd. (WVE) reported -$204.38M of net income, with a net margin of -478.3%.